Postpartum Hypertension and Recurrent HDP Risk: A BU Study

by Chief Editor

Researchers at the Boston University School of Public Health (BUSPH) and Boston Medical Center (BMC) are launching a $3.2 million study to determine if monitoring postpartum blood pressure can prevent recurrent hypertensive disorders of pregnancy (HDP). Led by Dr. Samantha Parker Kelleher and Dr. Christina Yarrington, the five-year project aims to identify early interventions for the 10 percent of U.S. pregnancies affected by conditions like preeclampsia, according to the National Heart, Lung, and Blood Institute.

Why is the postpartum window critical for heart health?

Up to 50 percent of women who experience HDP develop hypertension in the six weeks following birth, creating a narrow but vital window for medical intervention. Dr. Samantha Parker Kelleher, principal investigator and associate professor of epidemiology at BUSPH, notes that current maternal healthcare often waits until the next pregnancy to address these risks. By shifting the focus to the immediate postpartum period, clinicians hope to stabilize patients before they conceive again, potentially lowering the 15-45 percent recurrence rate of HDP observed in the United States.

Why is the postpartum window critical for heart health?
Did you know?

Hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia, are strongly linked to long-term cardiovascular issues, such as chronic hypertension and stroke, according to data from BUSPH.

How does remote monitoring change patient care?

The study will analyze data from 3,500 BMC patients using a cloud-connected blood pressure cuff program that began during the COVID-19 pandemic. According to Dr. Erica Holland, an obstetrician-gynecologist at BMC, this technology allows clinicians to manage elevated readings remotely and trigger urgent in-person evaluations when necessary. This proactive approach aims to reduce hospital readmissions and severe complications like seizures. Because BMC serves a high percentage of underserved populations, researchers believe this model offers a scalable solution to address health disparities, as Black and Hispanic pregnant people are disproportionately affected by HDP.

How does remote monitoring change patient care?

Can breastfeeding reduce the risk of recurrent HDP?

Researchers are examining whether breastfeeding duration influences the likelihood of developing HDP in subsequent pregnancies. Dr. Katherine Standish, founder of BMC’s Breastfeeding and Lactation Medicine Center, explains that improved cardiovascular indicators have been observed as early as one month after initiating breastfeeding. While the study explores the benefits of lactation, it also acknowledges the barriers faced by mothers who are already managing acute hypertensive disease. The team intends to use these findings to identify which patients would benefit most from lactation support and determine the optimal timing for such interventions.

New study delves into pregnancy, maternal health

What are the next steps for clinical guidelines?

A primary goal of the project is to provide data that could redefine when antihypertensive medications are prescribed. Currently, the threshold for defining hypertension in the monitoring program is 140/90 mmHg, though it was previously 150/100 mmHg. By comparing patient outcomes across these different thresholds, the team hopes to inform future clinical guidelines. Dr. Parker Kelleher emphasizes that the ultimate goal is to get mothers into a “good position to have healthy, uncomplicated pregnancies” by addressing risk factors long before a new pregnancy begins.

Pro Tip:

If you are planning a future pregnancy after experiencing HDP, consult your primary care physician about early interventions. Low-dose aspirin is currently the only evidence-based preventive treatment for recurrent HDP, but it must be started early in the subsequent pregnancy to be effective.

Frequently Asked Questions

What is the most effective way to prevent recurrent HDP?
Currently, low-dose aspirin is the only evidence-based preventive treatment, provided it is prescribed early in a subsequent pregnancy.
How does postpartum hypertension affect future health?
Postpartum hypertension is a significant risk factor for chronic heart disease, stroke, and the recurrence of hypertensive disorders in future pregnancies.
Why is the postpartum period considered “underutilized” in care?
Traditional maternal care focuses heavily on the prenatal period. Researchers at BUSPH argue that the first six weeks after birth provide a unique opportunity to identify and treat risk factors before a woman becomes pregnant again.

Are you interested in learning more about maternal health innovations? Subscribe to our weekly newsletter for the latest updates on medical research and health policy.

You may also like

Leave a Comment